메뉴 건너뛰기




Volumn 27, Issue 2, 2008, Pages 141-149

Multidisciplinary Insights on Clinical Guidance for the Use of Proliferation Signal Inhibitors in Heart Transplantation

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EVEROLIMUS; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

EID: 38949125143     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.08.014     Document Type: Article
Times cited : (66)

References (72)
  • 1
    • 1942468646 scopus 로고    scopus 로고
    • Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts
    • Schachner T., Zou Y., Oberhuber A., et al. Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts. Ann Thorac Surg 77 (2004) 1580-1585
    • (2004) Ann Thorac Surg , vol.77 , pp. 1580-1585
    • Schachner, T.1    Zou, Y.2    Oberhuber, A.3
  • 2
    • 38949178323 scopus 로고    scopus 로고
    • Everolimus reduces intimal proliferation in an ex vivo model of vascular injury
    • Cornelissen J., Gandlau-White A., Southwood M., et al. Everolimus reduces intimal proliferation in an ex vivo model of vascular injury. J Heart Lung Transplant 25 suppl (2006) 107
    • (2006) J Heart Lung Transplant , vol.25 , Issue.SUPPL , pp. 107
    • Cornelissen, J.1    Gandlau-White, A.2    Southwood, M.3
  • 3
    • 33947681290 scopus 로고    scopus 로고
    • Recommendations for the use of everolimus (Certican) in heart transplantation: results from the second German-Austrian Certican Consensus Conference
    • Rothenburger M., Zuckermann A., Bara C., et al. Recommendations for the use of everolimus (Certican) in heart transplantation: results from the second German-Austrian Certican Consensus Conference. J Heart Lung Transplant 26 (2007) 305-311
    • (2007) J Heart Lung Transplant , vol.26 , pp. 305-311
    • Rothenburger, M.1    Zuckermann, A.2    Bara, C.3
  • 5
    • 20844461132 scopus 로고    scopus 로고
    • Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years-a randomized clinical trial
    • Keogh A., Richardson M., Ruygrok P., et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years-a randomized clinical trial. Circulation 110 (2004) 2694-2700
    • (2004) Circulation , vol.110 , pp. 2694-2700
    • Keogh, A.1    Richardson, M.2    Ruygrok, P.3
  • 6
    • 19244366021 scopus 로고    scopus 로고
    • Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients
    • Eisen H.J., Tuzcu E.M., Dorent R., et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients. N Engl J Med 349 (2003) 847-858
    • (2003) N Engl J Med , vol.349 , pp. 847-858
    • Eisen, H.J.1    Tuzcu, E.M.2    Dorent, R.3
  • 7
    • 15044351065 scopus 로고    scopus 로고
    • Clinical experience with Certican (everolimus) in de novo heart transplant patients at the Deutsches Herzzentrum Berlin
    • Lehmkuhl H., and Hetzer R. Clinical experience with Certican (everolimus) in de novo heart transplant patients at the Deutsches Herzzentrum Berlin. J Heart Lung Transplant 24 suppl 4 (2005) 201-205
    • (2005) J Heart Lung Transplant , vol.24 , Issue.SUPPL. 4 , pp. 201-205
    • Lehmkuhl, H.1    Hetzer, R.2
  • 8
    • 15044345672 scopus 로고    scopus 로고
    • Clinical experience with Certican (everolimus) in maintenance heart transplant patients at the Medical University of Vienna
    • Zuckermann A. Clinical experience with Certican (everolimus) in maintenance heart transplant patients at the Medical University of Vienna. J Heart Lung Transplant 24 suppl 4 (2005) 206-209
    • (2005) J Heart Lung Transplant , vol.24 , Issue.SUPPL. 4 , pp. 206-209
    • Zuckermann, A.1
  • 9
    • 33646404334 scopus 로고    scopus 로고
    • Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients
    • Schweiger M., Wasler A., Prenner G., et al. Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients. Transplant Immunol 16 (2006) 46-51
    • (2006) Transplant Immunol , vol.16 , pp. 46-51
    • Schweiger, M.1    Wasler, A.2    Prenner, G.3
  • 10
    • 29544442185 scopus 로고    scopus 로고
    • Everolimus (Certican) in heart transplantation-optimizing renal function through minimizing cyclosporine exposure
    • Lehmkuhl H., Ross H., Eisen H., and Valantine H. Everolimus (Certican) in heart transplantation-optimizing renal function through minimizing cyclosporine exposure. Transplant Proc 37 (2005) 4145-4149
    • (2005) Transplant Proc , vol.37 , pp. 4145-4149
    • Lehmkuhl, H.1    Ross, H.2    Eisen, H.3    Valantine, H.4
  • 11
    • 33947699939 scopus 로고    scopus 로고
    • Neoral and Certican can safely be combined in stable cardiac transplant recipients: six week interim analysis of a Canadian pilot study
    • Ross H., Burton J., Pflugfelder P., Dorent R., and Loertscher R. Neoral and Certican can safely be combined in stable cardiac transplant recipients: six week interim analysis of a Canadian pilot study. Transplant Int 18 suppl 1 (2005) PO097
    • (2005) Transplant Int , vol.18 , Issue.SUPPL. 1
    • Ross, H.1    Burton, J.2    Pflugfelder, P.3    Dorent, R.4    Loertscher, R.5
  • 13
    • 37149054281 scopus 로고    scopus 로고
    • The role of everolimus in the improvement of renal function in heart transplant recipients
    • Fuchs U., Zittermann A., Tenderich G., et al. The role of everolimus in the improvement of renal function in heart transplant recipients. Transplant Int 18 suppl 1 (2005) PO094
    • (2005) Transplant Int , vol.18 , Issue.SUPPL. 1
    • Fuchs, U.1    Zittermann, A.2    Tenderich, G.3
  • 14
    • 0042360213 scopus 로고    scopus 로고
    • Chronic renal failure after transplantation of a nonrenal organ
    • Ojo A.O., Held P.J., Pork F.K., et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349 (2003) 931-940
    • (2003) N Engl J Med , vol.349 , pp. 931-940
    • Ojo, A.O.1    Held, P.J.2    Pork, F.K.3
  • 15
    • 0021280574 scopus 로고
    • Cyclosporine-associated chronic nephropathy
    • Myers B.D., Ross J., Newton L., et al. Cyclosporine-associated chronic nephropathy. N Engl J Med 311 (1984) 699-705
    • (1984) N Engl J Med , vol.311 , pp. 699-705
    • Myers, B.D.1    Ross, J.2    Newton, L.3
  • 16
    • 0026212083 scopus 로고
    • Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury
    • Myers B.D., and Newton L. Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury. J Am Soc Nephrol 2 suppl (1991) S45-S52
    • (1991) J Am Soc Nephrol , vol.2 , Issue.SUPPL
    • Myers, B.D.1    Newton, L.2
  • 18
    • 0038817791 scopus 로고    scopus 로고
    • Drug monitoring of sirolimus and everolimus
    • Armstrong V.W., and Streit F. Drug monitoring of sirolimus and everolimus. Lab Medizin 27 (2003) 222-227
    • (2003) Lab Medizin , vol.27 , pp. 222-227
    • Armstrong, V.W.1    Streit, F.2
  • 19
    • 0036253476 scopus 로고    scopus 로고
    • Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment
    • Snell G.I., Levvey B.J., Chin W., et al. Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment. J Heart Lung Transplant 21 (2002) 540-546
    • (2002) J Heart Lung Transplant , vol.21 , pp. 540-546
    • Snell, G.I.1    Levvey, B.J.2    Chin, W.3
  • 20
    • 21244454092 scopus 로고    scopus 로고
    • Initial experience with sirolimus and mycophenolate mofetil for renal rescue from cyclosporine nephrotoxicity after heart transplantation
    • Lyster H., Panicker G., Leaver N., and Banner N.R. Initial experience with sirolimus and mycophenolate mofetil for renal rescue from cyclosporine nephrotoxicity after heart transplantation. Transplant Proc 36 (2004) 3167-3170
    • (2004) Transplant Proc , vol.36 , pp. 3167-3170
    • Lyster, H.1    Panicker, G.2    Leaver, N.3    Banner, N.R.4
  • 21
    • 38949162105 scopus 로고    scopus 로고
    • Calcineurin inhibitor-free immunosuppression using everolimus in maintenance heart transplant recipients-9 months follow-up
    • Rothenburger M., Stypmann J., Loeher A., et al. Calcineurin inhibitor-free immunosuppression using everolimus in maintenance heart transplant recipients-9 months follow-up. Transplantation 82 suppl 2 (2006) 553
    • (2006) Transplantation , vol.82 , Issue.SUPPL. 2 , pp. 553
    • Rothenburger, M.1    Stypmann, J.2    Loeher, A.3
  • 22
    • 2642568316 scopus 로고    scopus 로고
    • Sirolimus and mycophenolate mofetil as calcineurin inhibitor-free immunosuppression in a cardiac transplant patient with chronic renal failure
    • Groetzner J., Kaczmarek I., Meiser B., et al. Sirolimus and mycophenolate mofetil as calcineurin inhibitor-free immunosuppression in a cardiac transplant patient with chronic renal failure. J Heart Lung Transplant 23 (2004) 770-773
    • (2004) J Heart Lung Transplant , vol.23 , pp. 770-773
    • Groetzner, J.1    Kaczmarek, I.2    Meiser, B.3
  • 23
    • 27844587421 scopus 로고    scopus 로고
    • Improvement of renal dysfunction by conversion from calcineurin inhibitors to sirolimus after heart transplantation
    • Hunt J., Lerman M., Magee M.J., et al. Improvement of renal dysfunction by conversion from calcineurin inhibitors to sirolimus after heart transplantation. J Heart Lung Transplant 24 (2005) 1863-1867
    • (2005) J Heart Lung Transplant , vol.24 , pp. 1863-1867
    • Hunt, J.1    Lerman, M.2    Magee, M.J.3
  • 24
    • 1542719221 scopus 로고    scopus 로고
    • Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients
    • Groetzner J., Kaczmarek I., Landwehr P., et al. Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients. Eur J Cardiothorac Surg 25 (2004) 333-341
    • (2004) Eur J Cardiothorac Surg , vol.25 , pp. 333-341
    • Groetzner, J.1    Kaczmarek, I.2    Landwehr, P.3
  • 25
    • 10744231167 scopus 로고    scopus 로고
    • Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure
    • Groetzner J., Meiser B., Landwehr P., et al. Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure. Transplantation 77 (2004) 568-574
    • (2004) Transplantation , vol.77 , pp. 568-574
    • Groetzner, J.1    Meiser, B.2    Landwehr, P.3
  • 26
    • 29144480970 scopus 로고    scopus 로고
    • Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity
    • Kushwaha S.S., Khalpey Z., Frantz R.P., et al. Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity. J Heart Lung Transplant 24 (2005) 2129-2136
    • (2005) J Heart Lung Transplant , vol.24 , pp. 2129-2136
    • Kushwaha, S.S.1    Khalpey, Z.2    Frantz, R.P.3
  • 27
    • 33645370770 scopus 로고    scopus 로고
    • Sirolimus in de novo heart transplant recipients with severe renal impairment
    • Vazquez de Prada J.A., Vilchez F.G., Cobo M., et al. Sirolimus in de novo heart transplant recipients with severe renal impairment. Transplant Int 19 (2006) 245-248
    • (2006) Transplant Int , vol.19 , pp. 245-248
    • Vazquez de Prada, J.A.1    Vilchez, F.G.2    Cobo, M.3
  • 29
    • 1342304173 scopus 로고    scopus 로고
    • Lymphomas after solid organ transplantation: a collaborative transplant study report
    • Opelz G., and Döhler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 4 (2003) 222-230
    • (2003) Am J Transplant , vol.4 , pp. 222-230
    • Opelz, G.1    Döhler, B.2
  • 30
    • 0027501649 scopus 로고
    • Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients
    • Opelz G., and Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 342 (1993) 1514-1516
    • (1993) Lancet , vol.342 , pp. 1514-1516
    • Opelz, G.1    Henderson, R.2
  • 31
    • 0032949981 scopus 로고    scopus 로고
    • Evaluation of individual and combined neurotoxicity of the immunosuppressants cyclosporine and sirolimus by in vitro multinuclear NMR spectroscopy
    • Serkova N., Litt L., James T.L., et al. Evaluation of individual and combined neurotoxicity of the immunosuppressants cyclosporine and sirolimus by in vitro multinuclear NMR spectroscopy. J Pharmacol Exp Ther 289 (1999) 800-806
    • (1999) J Pharmacol Exp Ther , vol.289 , pp. 800-806
    • Serkova, N.1    Litt, L.2    James, T.L.3
  • 32
    • 0034881393 scopus 로고    scopus 로고
    • Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain
    • Serkova N., Jacobsen W., Niemann C.U., et al. Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain. Br J Pharmacol 133 (2001) 875-885
    • (2001) Br J Pharmacol , vol.133 , pp. 875-885
    • Serkova, N.1    Jacobsen, W.2    Niemann, C.U.3
  • 33
    • 1542617940 scopus 로고    scopus 로고
    • Renal insufficiency and end-stage renal disease in the heart transplant population
    • Rubel J.R., Milford E.L., McKay D.B., and Jarcho J.A. Renal insufficiency and end-stage renal disease in the heart transplant population. J Heart Lung Transplant 23 (2004) 289-300
    • (2004) J Heart Lung Transplant , vol.23 , pp. 289-300
    • Rubel, J.R.1    Milford, E.L.2    McKay, D.B.3    Jarcho, J.A.4
  • 34
    • 33745393847 scopus 로고    scopus 로고
    • Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report
    • Kobashigawa J.A., Miller L.W., Russell S.D., et al. Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. Am J Transplant 6 (2006) 1377-1386
    • (2006) Am J Transplant , vol.6 , pp. 1377-1386
    • Kobashigawa, J.A.1    Miller, L.W.2    Russell, S.D.3
  • 35
    • 33745288559 scopus 로고    scopus 로고
    • Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients
    • Kuppahally S., Al-Khaldi A., Weisshaar D., et al. Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients. Am J Transplant 6 (2006) 986-992
    • (2006) Am J Transplant , vol.6 , pp. 986-992
    • Kuppahally, S.1    Al-Khaldi, A.2    Weisshaar, D.3
  • 36
    • 18544381706 scopus 로고    scopus 로고
    • Clinical experience with everolimus (Certican): optimizing dose and tolerability
    • Pascual J., Marcén R., and Ortuño J. Clinical experience with everolimus (Certican): optimizing dose and tolerability. Transplantation 79 suppl (2005) S80-S84
    • (2005) Transplantation , vol.79 , Issue.SUPPL
    • Pascual, J.1    Marcén, R.2    Ortuño, J.3
  • 37
    • 29544448704 scopus 로고    scopus 로고
    • Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: a multicenter study
    • Ruiz J.C., Diekmann F., Campistol J.M., et al. Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients: a multicenter study. Transplant Proc 37 (2005) 3833-3835
    • (2005) Transplant Proc , vol.37 , pp. 3833-3835
    • Ruiz, J.C.1    Diekmann, F.2    Campistol, J.M.3
  • 38
    • 33750008433 scopus 로고    scopus 로고
    • Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction
    • Ruiz J.C., Campistol J.M., Sanchez-Fructuoso A., et al. Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction. Nephrol Dial Transplant 21 (2006) 3252-3257
    • (2006) Nephrol Dial Transplant , vol.21 , pp. 3252-3257
    • Ruiz, J.C.1    Campistol, J.M.2    Sanchez-Fructuoso, A.3
  • 39
    • 7244245756 scopus 로고    scopus 로고
    • Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction
    • Diekmann F., Budde K., Oppenheimer F., et al. Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction. Am J Transplant 4 (2004) 1869-1875
    • (2004) Am J Transplant , vol.4 , pp. 1869-1875
    • Diekmann, F.1    Budde, K.2    Oppenheimer, F.3
  • 40
    • 35048832248 scopus 로고    scopus 로고
    • Elevated serum levels of vascular endothelial growth factor (VEGF) and proteinuria in renal allograft recipients treated with mTOR inhibitors
    • Stracke S., Mayer J.M., Henne-Bruns D., and Keller F. Elevated serum levels of vascular endothelial growth factor (VEGF) and proteinuria in renal allograft recipients treated with mTOR inhibitors. Transplantation 82 suppl 2 (2006) 299
    • (2006) Transplantation , vol.82 , Issue.SUPPL. 2 , pp. 299
    • Stracke, S.1    Mayer, J.M.2    Henne-Bruns, D.3    Keller, F.4
  • 41
    • 34547592986 scopus 로고    scopus 로고
    • Development of proteinuria after switch to sirolimus based immunosuppression in long-term cardiac transplant patients
    • Aliabadi A.Z., Kammerstätter D.P., Seebacher G., et al. Development of proteinuria after switch to sirolimus based immunosuppression in long-term cardiac transplant patients. Transplantation 82 suppl 2 (2006) 562
    • (2006) Transplantation , vol.82 , Issue.SUPPL. 2 , pp. 562
    • Aliabadi, A.Z.1    Kammerstätter, D.P.2    Seebacher, G.3
  • 42
    • 33644928466 scopus 로고    scopus 로고
    • Sirolimus-associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism
    • Straathof-Galema L., Wetzels J.F., Dijkman H.B., Steenbergen E.J., and Hilbrands L.B. Sirolimus-associated heavy proteinuria in a renal transplant recipient: evidence for a tubular mechanism. Am J Transplant 6 (2006) 429-433
    • (2006) Am J Transplant , vol.6 , pp. 429-433
    • Straathof-Galema, L.1    Wetzels, J.F.2    Dijkman, H.B.3    Steenbergen, E.J.4    Hilbrands, L.B.5
  • 43
    • 0037623516 scopus 로고    scopus 로고
    • Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience
    • Morelon E., and Kreis H. Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience. Transplant Proc 35 (2003) 52-57
    • (2003) Transplant Proc , vol.35 , pp. 52-57
    • Morelon, E.1    Kreis, H.2
  • 44
    • 33745767702 scopus 로고    scopus 로고
    • Long-term cardiovascular risk in transplantation-insights from the use of everolimus in heart transplantation
    • Eisen H. Long-term cardiovascular risk in transplantation-insights from the use of everolimus in heart transplantation. Nephrol Dial Transplant 21 suppl 3 (2006) iii9-iii13
    • (2006) Nephrol Dial Transplant , vol.21 , Issue.SUPPL. 3
    • Eisen, H.1
  • 45
    • 33750377251 scopus 로고    scopus 로고
    • The impact of proliferation signal inhibitors on the healthcare burden of major adverse cardiac events following heart transplantation
    • Eisen H., and Yang X. The impact of proliferation signal inhibitors on the healthcare burden of major adverse cardiac events following heart transplantation. Transplantation 82 (2006) 13-18
    • (2006) Transplantation , vol.82 , pp. 13-18
    • Eisen, H.1    Yang, X.2
  • 46
    • 20844455929 scopus 로고    scopus 로고
    • Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression
    • Caforio A.L., Tona F., Fortina A.B., et al. Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression. Am J Transplant 4 (2004) 962-970
    • (2004) Am J Transplant , vol.4 , pp. 962-970
    • Caforio, A.L.1    Tona, F.2    Fortina, A.B.3
  • 47
    • 27644436740 scopus 로고    scopus 로고
    • Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies
    • Kauffman H.M., Cherikh W.S., Cheng Y., et al. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 80 (2005) 883-889
    • (2005) Transplantation , vol.80 , pp. 883-889
    • Kauffman, H.M.1    Cherikh, W.S.2    Cheng, Y.3
  • 48
    • 20144367584 scopus 로고    scopus 로고
    • Sirolimus for Kaposi's sarcoma in renal-transplant recipients
    • Stallone G., Schena A., Infante B., et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 352 (2005) 1317-1323
    • (2005) N Engl J Med , vol.352 , pp. 1317-1323
    • Stallone, G.1    Schena, A.2    Infante, B.3
  • 49
    • 33748189496 scopus 로고    scopus 로고
    • Sirolimus (SRL) in heart transplantation: preliminary results of a multicenter registry in Spain (Rapacor study)
    • Delgado J., Crespo M.G., Manito N., et al. Sirolimus (SRL) in heart transplantation: preliminary results of a multicenter registry in Spain (Rapacor study). Am J Transplant 5 suppl 11 (2005) S172
    • (2005) Am J Transplant , vol.5 , Issue.SUPPL. 11
    • Delgado, J.1    Crespo, M.G.2    Manito, N.3
  • 50
    • 0038300674 scopus 로고    scopus 로고
    • Use of rapamycin slows progression of cardiac transplant vasculopathy
    • Mancini D., Pinney S., Burkhoff D., et al. Use of rapamycin slows progression of cardiac transplant vasculopathy. Circulation 107 (2003) 48-53
    • (2003) Circulation , vol.107 , pp. 48-53
    • Mancini, D.1    Pinney, S.2    Burkhoff, D.3
  • 51
    • 4243198694 scopus 로고    scopus 로고
    • Rapastat: evaluation of the role of oral sirolimus in the treatment of established graft vessel disease. A prospective, randomized intravascular ultrasound study
    • Segovia J., Alonso-Pulpon L., Ortiz P., et al. Rapastat: evaluation of the role of oral sirolimus in the treatment of established graft vessel disease. A prospective, randomized intravascular ultrasound study. J Heart Lung Transplant 23 suppl 2 (2004) S51
    • (2004) J Heart Lung Transplant , vol.23 , Issue.SUPPL. 2
    • Segovia, J.1    Alonso-Pulpon, L.2    Ortiz, P.3
  • 52
    • 0037296071 scopus 로고    scopus 로고
    • Rapamycin as rescue therapy in a patient supported by biventricular assist device to heart transplantation with consecutive ongoing rejection
    • Ankersmit H.J., Roth G., Zuckermann A., et al. Rapamycin as rescue therapy in a patient supported by biventricular assist device to heart transplantation with consecutive ongoing rejection. Am J Transplant 3 (2003) 231-234
    • (2003) Am J Transplant , vol.3 , pp. 231-234
    • Ankersmit, H.J.1    Roth, G.2    Zuckermann, A.3
  • 53
    • 33645458234 scopus 로고    scopus 로고
    • Sirolimus therapy after early cyclosporine withdrawal reduces the risk of cancer in adult renal transplantation
    • Campistol J.M., Eris J., Oberbauer R., et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk of cancer in adult renal transplantation. J Am Soc Nephrol 17 (2006) 581-589
    • (2006) J Am Soc Nephrol , vol.17 , pp. 581-589
    • Campistol, J.M.1    Eris, J.2    Oberbauer, R.3
  • 54
    • 10044246181 scopus 로고    scopus 로고
    • Therapeutic drug monitoring for everolimus in heart transplant recipients based on exposure-effect modeling
    • Starling R.C., Hare J.M., Hauptman P., et al. Therapeutic drug monitoring for everolimus in heart transplant recipients based on exposure-effect modeling. Am J Transplant 4 (2004) 2126-2131
    • (2004) Am J Transplant , vol.4 , pp. 2126-2131
    • Starling, R.C.1    Hare, J.M.2    Hauptman, P.3
  • 56
    • 23944471153 scopus 로고    scopus 로고
    • Deep sternal wound infection after cardiac surgery: modality of treatment and outcome
    • Immer F.F., Durrer M., Mühlemann K.S., et al. Deep sternal wound infection after cardiac surgery: modality of treatment and outcome. Ann Thorac Surg 80 (2005) 957-961
    • (2005) Ann Thorac Surg , vol.80 , pp. 957-961
    • Immer, F.F.1    Durrer, M.2    Mühlemann, K.S.3
  • 57
    • 24944484995 scopus 로고    scopus 로고
    • Vacuum-assisted closure for sternal wounds: a first-line therapeutic management approach
    • Agarwal J.P., Ogilvie M., Wu L.C., et al. Vacuum-assisted closure for sternal wounds: a first-line therapeutic management approach. Plast Reconstr Surg 116 (2005) 1035-1040
    • (2005) Plast Reconstr Surg , vol.116 , pp. 1035-1040
    • Agarwal, J.P.1    Ogilvie, M.2    Wu, L.C.3
  • 58
    • 33645841612 scopus 로고    scopus 로고
    • Everolimus (Certican) in renal transplantation: a review of clinical trial data, current usage, and future directions
    • Pascual J., Boletis I.N., and Campistol J.M. Everolimus (Certican) in renal transplantation: a review of clinical trial data, current usage, and future directions. Transplant Rev 20 (2006) 1-18
    • (2006) Transplant Rev , vol.20 , pp. 1-18
    • Pascual, J.1    Boletis, I.N.2    Campistol, J.M.3
  • 59
    • 0029692603 scopus 로고    scopus 로고
    • Thoracoscopic creation of a pericardial window for recurrent pericardial effusion after heart transplantation
    • Brandt M., Brückner M., Hirt S.W., et al. Thoracoscopic creation of a pericardial window for recurrent pericardial effusion after heart transplantation. Eur J Cardio-thorac Surg 10 (1996) 220-222
    • (1996) Eur J Cardio-thorac Surg , vol.10 , pp. 220-222
    • Brandt, M.1    Brückner, M.2    Hirt, S.W.3
  • 61
    • 0034065402 scopus 로고    scopus 로고
    • Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus
    • MacDonald A., Scarola J., Burke J.T., and Zimmerman J.J. Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus. Clin Ther 22 suppl B (2000) B101-B121
    • (2000) Clin Ther , vol.22 , Issue.SUPPL. B
    • MacDonald, A.1    Scarola, J.2    Burke, J.T.3    Zimmerman, J.J.4
  • 62
    • 0033729567 scopus 로고    scopus 로고
    • Pharmacokinetics of SDZ RAD and cyclosporin including their metabolites in seven kidney graft patients after the first dose of SDZ RAD
    • Kirchner G.I., Winkler M., Mueller L., et al. Pharmacokinetics of SDZ RAD and cyclosporin including their metabolites in seven kidney graft patients after the first dose of SDZ RAD. Br J Clin Pharmacol 50 (2000) 449-454
    • (2000) Br J Clin Pharmacol , vol.50 , pp. 449-454
    • Kirchner, G.I.1    Winkler, M.2    Mueller, L.3
  • 63
    • 0030832514 scopus 로고    scopus 로고
    • SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo
    • Schuler W., Sedrani R., Cottens S., et al. SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo. Transplantation 64 (1997) 36-42
    • (1997) Transplantation , vol.64 , pp. 36-42
    • Schuler, W.1    Sedrani, R.2    Cottens, S.3
  • 64
    • 33745197501 scopus 로고    scopus 로고
    • Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice
    • Grigioni F., Carigi S., Potena L., et al. Long-term safety and effectiveness of statins for heart transplant recipients in routine clinical practice. Transplant Proc 38 (2006) 1507-1510
    • (2006) Transplant Proc , vol.38 , pp. 1507-1510
    • Grigioni, F.1    Carigi, S.2    Potena, L.3
  • 65
    • 27844521938 scopus 로고    scopus 로고
    • Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients
    • Kobashigawa J.A., Moriguchi J.D., Laks H., et al. Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients. J Heart Lung Transplant 24 (2005) 1736-1740
    • (2005) J Heart Lung Transplant , vol.24 , pp. 1736-1740
    • Kobashigawa, J.A.1    Moriguchi, J.D.2    Laks, H.3
  • 66
    • 17844373853 scopus 로고    scopus 로고
    • Immunosuppressive therapy with everolimus can be associated with potentially life-threatening lingual angioedema
    • Fuchs U., Zittermann A., Berthold H.K., et al. Immunosuppressive therapy with everolimus can be associated with potentially life-threatening lingual angioedema. Transplantation 79 (2005) 981-983
    • (2005) Transplantation , vol.79 , pp. 981-983
    • Fuchs, U.1    Zittermann, A.2    Berthold, H.K.3
  • 67
    • 20344387487 scopus 로고    scopus 로고
    • Preservation of renal function after heart transplantation: initial single-center experience with sirolimus
    • De Meester J.M., Van Vlem B., Walravens M., et al. Preservation of renal function after heart transplantation: initial single-center experience with sirolimus. Transplant Proc 37 (2005) 1835-1838
    • (2005) Transplant Proc , vol.37 , pp. 1835-1838
    • De Meester, J.M.1    Van Vlem, B.2    Walravens, M.3
  • 68
    • 33745006874 scopus 로고    scopus 로고
    • Acne in recipients of renal transplantation treated with sirolimus: clinical, microbiologic, histologic, therapeutic, and pathogenic aspects
    • Mahe E., Morelon E., Lechaton S., et al. Acne in recipients of renal transplantation treated with sirolimus: clinical, microbiologic, histologic, therapeutic, and pathogenic aspects. J Am Acad Dermatol 55 (2006) 139-142
    • (2006) J Am Acad Dermatol , vol.55 , pp. 139-142
    • Mahe, E.1    Morelon, E.2    Lechaton, S.3
  • 69
    • 33646096245 scopus 로고    scopus 로고
    • Resolution of sirolimus-induced pneumonitis after conversion to everolimus
    • Rehm B., Keller F., Mayer J., and Stracke S. Resolution of sirolimus-induced pneumonitis after conversion to everolimus. Transplant Proc 38 (2006) 711-713
    • (2006) Transplant Proc , vol.38 , pp. 711-713
    • Rehm, B.1    Keller, F.2    Mayer, J.3    Stracke, S.4
  • 70
    • 31544443523 scopus 로고    scopus 로고
    • Reversible sirolimus-associated pneumonitis after heart transplantation
    • Hamour I.M., Mittal T.K., Bell A.D., and Banner N.R. Reversible sirolimus-associated pneumonitis after heart transplantation. J Heart Lung Transplant 25 (2006) 241-244
    • (2006) J Heart Lung Transplant , vol.25 , pp. 241-244
    • Hamour, I.M.1    Mittal, T.K.2    Bell, A.D.3    Banner, N.R.4
  • 71
    • 33748129890 scopus 로고    scopus 로고
    • Sirolimus-associated interstitial pneumonitis in 3 heart transplant recipients
    • Delgado J.F., Torres J., Ruiz-Cano M.J., et al. Sirolimus-associated interstitial pneumonitis in 3 heart transplant recipients. J Heart Lung Transplant 25 (2006) 1171-1174
    • (2006) J Heart Lung Transplant , vol.25 , pp. 1171-1174
    • Delgado, J.F.1    Torres, J.2    Ruiz-Cano, M.J.3
  • 72
    • 0031708127 scopus 로고    scopus 로고
    • Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease
    • Kerman R.H., Susskind B., Kerman D., et al. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease. J Heart Lung Transplant 17 (1998) 789-794
    • (1998) J Heart Lung Transplant , vol.17 , pp. 789-794
    • Kerman, R.H.1    Susskind, B.2    Kerman, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.